Adipocyte NR1D1 dictates adipose tissue expansion during obesity

From eLife via Jisc Publications RouterHistory: received 2020-09-22, collection 2021, accepted 2021-07-30, pub-electronic 2021-08-05Publication status: PublishedFunder: Biotechnology and Biological Sciences Research Council; FundRef: http://dx.doi.org/10.13039/501100000268; Grant(s): BB/I018654/1Funder: Medical Research Council; FundRef: http://dx.doi.org/10.13039/501100000265; Grant(s): MR/N021479/1Funder: Medical Research Council; FundRef: http://dx.doi.org/10.13039/501100000265; Grant(s): MR/P00279X/1Funder: Medical Research Council; FundRef: http://dx.doi.org/10.13039/501100000265; Grant(s): MR/P011853/1Funder: Medical Research Council; FundRef: http://dx.doi.org/10.13039/501100000265; Grant(s): MR/P023576/1Funder: Wellcome Trust; FundRef: http://dx.doi.org/10.13039/100004440; Grant(s): 107849/Z/15/ZFunder: Wellcome Trust; FundRef: http://dx.doi.org/10.13039/100004440; Grant(s): 107851/Z/15/ZThe circadian clock component NR1D1 (REVERBα) is considered a dominant regulator of lipid metabolism, with global Nr1d1 deletion driving dysregulation of white adipose tissue (WAT) lipogenesis and obesity. However, a similar phenotype is not observed under adipocyte-selective deletion (Nr1d1Flox2-6:AdipoqCre), and transcriptional profiling demonstrates that, under basal conditions, direct targets of NR1D1 regulation are limited, and include the circadian clock and collagen dynamics. Under high-fat diet (HFD) feeding, Nr1d1Flox2-6:AdipoqCre mice do manifest profound obesity, yet without the accompanying WAT inflammation and fibrosis exhibited by controls. Integration of the WAT NR1D1 cistrome with differential gene expression reveals broad control of metabolic processes by NR1D1 which is unmasked in the obese state. Adipocyte NR1D1 does not drive an anticipatory daily rhythm in WAT lipogenesis, but rather modulates WAT activity in response to alterations in metabolic state. Importantly, NR1D1 action in adipocytes is critical to the development of obesity-related WAT pathology and insulin resistance